title: Synergistic cytotoxicity of cisplatin and Taxol in overcoming Taxol resistance through the inhibition of LDHA in oral squamous cell carcinoma.
abstract: The development of chemoresistance in patients represents a major challenge in cancer treatment. Lactate dehydrogenase-A (LDHA) is one of the principle isoforms of LDH that is expressed in breast tissue, controlling the conversion of pyruvate to lactate and also playing a significant role in the metabolism of glucose. The aim of this study was to identify whether LDHA was involved in oral cancer cell resistance to Taxol and whether the downregulation of LDHA, as a result of cisplatin treatment, may overcome Taxol resistance in human oral squamous cells. The OECM-1 oral epidermal carcinoma cell line was used, which has been widely used as a model of oral cancer in previous studies. The role of LDHA in Taxol and cisplatin resistance were investigated and the synergistic cytotoxicity of cisplatin and/or Taxol in oral squamous cells was analyzed. Cell viability was analyzed by MTT assay, LDHA expression was analyzed by western blot analysis and siRNA tranfection was performed to knock down LDHA expression. The present study results showed that decreased levels of LDHA were responsible for the resistance of oral cancer cells to cisplatin (CDDP). CDDP treatments downregulated LDHA expression, and lower levels of LDHA were detected in the CDDP-resistant oral cancer cells compared with the CDDP-sensitive cells. By contrast, the Taxol-resistant cancer cells showed elevated LDHA expression levels. In addition, small interfering RNA-knockdown of LDHA sensitized the cells to Taxol, but desensitized them to CDDP treatment, while exogenous expression of LDHA sensitized the cells to CDDP, but desensitized them to Taxol. The present study also revealed the synergistic cytotoxicity of CDDP and Taxol for killing oral cancer cells through the inhibition of LDHA. This study highlights LDHA as a novel therapeutic target for overcoming Taxol resistance in oral cancer patients using the combined treatments of Taxol and CDDP.
authors: Institute of Stomatology, Chinese People's Liberation Army General Hospital, Beijing 100853, P.R. China.
authors: Lin
authors: L
authors: Feng
authors: Institute of Stomatology, Chinese People's Liberation Army General Hospital, Beijing 100853, P.R. China.
authors: Ling-Ling
authors: LL
authors: E
authors: Oral Medical Research Center, Saint-Petersburg Medical University, Saint-Petersburg 197101, Russia.
authors: Michail Michailovich
authors: MM
authors: Soloveiv
authors: Institute of Stomatology, Chinese People's Liberation Army General Hospital, Beijing 100853, P.R. China.
authors: Dong-Sheng
authors: DS
authors: Wang
authors: Institute of Stomatology, Chinese People's Liberation Army General Hospital, Beijing 100853, P.R. China.
authors: B O
authors: BO
authors: Zhang
authors: Institute of Stomatology, Chinese People's Liberation Army General Hospital, Beijing 100853, P.R. China.
authors: Yu Wan
authors: YW
authors: Dong
authors: Institute of Stomatology, Chinese People's Liberation Army General Hospital, Beijing 100853, P.R. China.
authors: Hong-Chen
authors: HC
authors: Liu
keywords: Taxol resistance; cisplatin resistance; glucose metabolism; oral squamous cell carcinoma